Symbol
| DBH
| contributors: mct - updated : 07-11-2022
|
HGNC name
| dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
HGNC id
| 2689
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
|  
| loss of function
|
DBH activity is statistically significantly decreased in non-treated depressive disorder and ADHD in children and adolescents | |
Susceptibility
|
to decreased DBH with attention-deficit, hyperactivity disorder to migraine with aura |
Variant & Polymorphism
SNP
, other
| SNP 1021C->T |
|
|
Candidate gene
| major QTL for plasma activity |
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
miscelleaneous | hypertension | | |
potential drug target to combat hypertension |
| | |
| overexpressed in human beta hydroxylase transgenic mice |